Roberto, Giuseppe http://orcid.org/0000-0001-6478-6442
,
Bartolini, Claudia
Rea, Federico
Onder, Graziano
Vitale, Cristiana
Trifirò, Gianluca
Kirchmayer, Ursula
Chinellato, Alessandro
Lucenteforte, Ersilia
Corrao, Giovanni
Mugelli, Alessandro
Lapi, Francesco
Gini, Rosa
Funding for this research was provided by:
Agenzia Italiana del Farmaco (FARM9LBBBL)
Article History
Received: 20 September 2017
Accepted: 3 January 2018
First Online: 30 January 2018
Compliance with ethical standards
:
: AM received research support from the Italian Medicine Agency (AIFA), the Italian Ministry for University and Research (MIUR), Gilead, and Menarini. In the last 2 years, he has received personal fees as speaker/consultant from Menarini Group, IBSA, Molteni, Angelini, and Pfizer Alliance. EL received research support from AIFA, which is not related to this study. Giovanni Corrao received research support from the European Community (EC), AIFA, and MIUR, and Italian Ministry of Health. He participated to a variety of projects funded by pharmaceutical companies (i.e., Novartis, GSK, Roche, AMGEN, and BMS) and received honoraria as member of Advisory Board from Roche and MA provider. FL has provided consultancies in protocol preparation for epidemiological studies and data analyses for IBSA, Angelini, and Bayer. All the remaining authors have no conflict of interest to declare.